{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"8.3","upperLimit":"100.0","value":"66.67"},{"groupId":"OG001","lowerLimit":"0.0","upperLimit":"100.0","value":"66.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"100"},{"groupId":"OG001","value":"97"}],"units":"Participants"}],"title":"Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.0","upperLimit":"100.0","value":"66.67"},{"groupId":"OG001","lowerLimit":"16.7","upperLimit":"100.0","value":"66.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"95"},{"groupId":"OG001","value":"89"}],"units":"Participants"}],"title":"Treatment - week 4"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"16.7","upperLimit":"100.0","value":"75.0"},{"groupId":"OG001","lowerLimit":"16.7","upperLimit":"100.0","value":"75.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"89"},{"groupId":"OG001","value":"84"}],"units":"Participants"}],"title":"Treatment - week 8"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"25.0","upperLimit":"100.0","value":"75.0"},{"groupId":"OG001","lowerLimit":"33.3","upperLimit":"100.0","value":"75.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"75"},{"groupId":"OG001","value":"78"}],"units":"Participants"}],"title":"Treatment - week 12"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"16.7","upperLimit":"100.0","value":"75.0"},{"groupId":"OG001","lowerLimit":"16.7","upperLimit":"100.0","value":"83.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"79"},{"groupId":"OG001","value":"73"}],"units":"Participants"}],"title":"Treatment - week 16"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"16.7","upperLimit":"100.0","value":"75.0"},{"groupId":"OG001","lowerLimit":"16.7","upperLimit":"100.0","value":"75.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"73"},{"groupId":"OG001","value":"67"}],"units":"Participants"}],"title":"Treatment - week 20"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"16.7","upperLimit":"100.0","value":"75.0"},{"groupId":"OG001","lowerLimit":"8.3","upperLimit":"100.0","value":"83.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"77"},{"groupId":"OG001","value":"71"}],"units":"Participants"}],"title":"Treatment - week 24"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"33.3","upperLimit":"100.0","value":"75.0"},{"groupId":"OG001","lowerLimit":"33.3","upperLimit":"100.0","value":"75.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"62"}],"units":"Participants"}],"title":"Treatment - week 28"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"33.3","upperLimit":"100.0","value":"75.0"},{"groupId":"OG001","lowerLimit":"8.3","upperLimit":"100.0","value":"66.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"73"},{"groupId":"OG001","value":"65"}],"units":"Participants"}],"title":"Treatment - week 32"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"16.7","upperLimit":"100.0","value":"79.17"},{"groupId":"OG001","lowerLimit":"16.7","upperLimit":"100.0","value":"66.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"64"},{"groupId":"OG001","value":"61"}],"units":"Participants"}],"title":"Treatment - week 36"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"16.7","upperLimit":"100.0","value":"75.0"},{"groupId":"OG001","lowerLimit":"33.3","upperLimit":"100.0","value":"83.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"74"},{"groupId":"OG001","value":"50"}],"units":"Participants"}],"title":"Treatment - week 40"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"16.7","upperLimit":"100.0","value":"83.33"},{"groupId":"OG001","lowerLimit":"16.7","upperLimit":"100.0","value":"83.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"47"}],"units":"Participants"}],"title":"Treatment - week 44"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"25.0","upperLimit":"100.0","value":"66.67"},{"groupId":"OG001","lowerLimit":"41.7","upperLimit":"100.0","value":"83.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"47"}],"units":"Participants"}],"title":"Treatment - week 48"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"16.7","upperLimit":"100.0","value":"83.33"},{"groupId":"OG001","lowerLimit":"41.7","upperLimit":"100.0","value":"75.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"44"}],"units":"Participants"}],"title":"Treatment - week 52"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"16.7","upperLimit":"100.0","value":"75.0"},{"groupId":"OG001","lowerLimit":"41.7","upperLimit":"100.0","value":"75.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"61"},{"groupId":"OG001","value":"48"}],"units":"Participants"}],"title":"Treatment - week 56"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"33.3","upperLimit":"100.0","value":"75.0"},{"groupId":"OG001","lowerLimit":"50.0","upperLimit":"100.0","value":"75.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"39"}],"units":"Participants"}],"title":"Treatment - week 60"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"33.3","upperLimit":"100.0","value":"75.0"},{"groupId":"OG001","lowerLimit":"41.7","upperLimit":"100.0","value":"83.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"55"},{"groupId":"OG001","value":"39"}],"units":"Participants"}],"title":"Treatment - week 64"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"33.3","upperLimit":"100.0","value":"75.0"},{"groupId":"OG001","lowerLimit":"33.3","upperLimit":"100.0","value":"79.17"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"49"},{"groupId":"OG001","value":"34"}],"units":"Participants"}],"title":"Treatment - week 68"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"33.3","upperLimit":"100.0","value":"75.0"},{"groupId":"OG001","lowerLimit":"8.3","upperLimit":"100.0","value":"75.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"54"},{"groupId":"OG001","value":"34"}],"units":"Participants"}],"title":"Treatment - week 72"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"41.7","upperLimit":"100.0","value":"75.0"},{"groupId":"OG001","lowerLimit":"16.7","upperLimit":"100.0","value":"75.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"29"}],"units":"Participants"}],"title":"Treatment - week 76"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"33.3","upperLimit":"100.0","value":"75.0"},{"groupId":"OG001","lowerLimit":"33.3","upperLimit":"100.0","value":"75.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"23"}],"units":"Participants"}],"title":"Treatment - week 80"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"41.7","upperLimit":"100.0","value":"83.33"},{"groupId":"OG001","lowerLimit":"33.3","upperLimit":"100.0","value":"66.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"19"}],"units":"Participants"}],"title":"Treatment - week 84"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"33.3","upperLimit":"100.0","value":"75.0"},{"groupId":"OG001","lowerLimit":"33.3","upperLimit":"100.0","value":"66.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"16"}],"units":"Participants"}],"title":"Treatment - week 88"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"33.3","upperLimit":"100.0","value":"70.83"},{"groupId":"OG001","lowerLimit":"50.0","upperLimit":"100.0","value":"75.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"13"}],"units":"Participants"}],"title":"Treatment - week 92"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"33.3","upperLimit":"100.0","value":"66.67"},{"groupId":"OG001","lowerLimit":"33.3","upperLimit":"100.0","value":"66.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"11"}],"units":"Participants"}],"title":"Treatment - week 96"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"25.0","upperLimit":"100.0","value":"66.67"},{"groupId":"OG001","lowerLimit":"33.3","upperLimit":"100.0","value":"75.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"10"}],"units":"Participants"}],"title":"Treatment - week 100"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"50.0","upperLimit":"100.0","value":"66.67"},{"groupId":"OG001","lowerLimit":"50.0","upperLimit":"100.0","value":"66.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"7"}],"units":"Participants"}],"title":"Treatment - week 104"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"50.0","upperLimit":"100.0","value":"66.67"},{"groupId":"OG001","lowerLimit":"33.3","upperLimit":"100.0","value":"75.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"7"}],"units":"Participants"}],"title":"Treatment - week 108"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"50.0","upperLimit":"100.0","value":"75.0"},{"groupId":"OG001","lowerLimit":"33.3","upperLimit":"100.0","value":"75.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"4"}],"units":"Participants"}],"title":"Treatment - week 112"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"41.7","upperLimit":"100.0","value":"70.83"},{"groupId":"OG001","lowerLimit":"83.3","upperLimit":"100.0","value":"91.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Treatment - week 116"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"50.0","upperLimit":"100.0","value":"83.3"},{"comment":"Not evaluable at week 120","groupId":"OG001","lowerLimit":"NA","upperLimit":"NA","value":"NA"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"151"}],"units":"Participants"}],"title":"Treatment - week 120"}],"denoms":[{"counts":[{"groupId":"OG000","value":"152"},{"groupId":"OG001","value":"151"}],"units":"Participants"}],"description":"The EORTC QLQ-C30 questionnaire consisted of 30 questions generating five functional scores (physical, role, cognitive, emotional, and social); a global health status/global quality of life scale score; three symptom scale scores (fatigue, pain, and nausea and vomiting); and six stand alone one-item scores that capture additional symptoms (dyspnea, appetite loss, sleep disturbance, constipation, and diarrhea) and perceived financial burden. All the scales and single-item scores were linearly transformed so that each score ranged from 0 to 100. A higher score on the global health and functioning subscales is indicative of better functioning.","dispersionType":"Full Range","groups":[{"description":"Participants received alectinib at 600 mg orally BID from Visit 0 (baseline) until disease progression, unacceptable toxicity, withdrawal of consent or death.","id":"OG000","title":"Alectinib"},{"description":"Participants received crizotinib at 250 mg orally BID from Visit 0 (baseline) until disease progression, unacceptable toxicity, withdrawal of consent or death.","id":"OG001","title":"Crizotinib"}],"paramType":"MEDIAN","populationDescription":"ITT population included all participants randomized in the study, irrespective of whether or not they received study drug. Number analyzed indicates number of participants evaluated for specified time points.","reportingStatus":"POSTED","timeFrame":"Baseline, every 4 weeks until disease progression (up to 33 months)","title":"Health-Related Quality of Life (HRQoL) by EORTC Quality of Life Questionnaire C30 Score","type":"SECONDARY","unitOfMeasure":"Score on a scale"}